SRPT
Sarepta Therapeutics Inc
17.90$
-2.0%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | 2.4% | 1.5% | 1.5% | 6.7% | 6.2% | 8.6% | 9.2% | 11.1% | 15.6% | 13.9% | 16.8% | 13.2% | 15.5% | 11.1% | 9.7% | 10.4% | 15.4% | 15.2% | 11.9% | 12.4% | 15.8% | 14.9% | 16.2% | 17.4% | 11.9% | 13.8% | 13.1% | 11.2% | 11.1% | 12.2% | 12.3% | 19.6% | 20.1% | 18.5% | 25.0% | 37.8% | 90.0% | 16.3% | 37.2% | 41.4% | |
| – | 97.6% | 98.5% | 98.5% | 93.3% | 93.8% | 91.4% | 90.8% | 88.9% | 84.4% | 86.1% | 83.2% | 86.8% | 84.5% | 88.9% | 90.3% | 89.6% | 84.6% | 84.8% | 88.1% | 87.6% | 84.2% | 85.1% | 83.8% | 82.6% | 88.1% | 86.2% | 86.9% | 88.8% | 88.9% | 87.8% | 87.7% | 80.4% | 79.9% | 81.5% | 75.0% | 62.2% | 10.0% | 83.7% | 62.8% | 58.6% | |
| – | 1,305.1% | 178.2% | 168.3% | 74.5% | 77.6% | 71.5% | 167.1% | 110.3% | 173.2% | 104.1% | 119.6% | 135.2% | 222.9% | 119.8% | 137.2% | 132.3% | 142.8% | 132.8% | 146.0% | 73.4% | 97.9% | 92.1% | 108.1% | 94.1% | 82.7% | 96.9% | 92.6% | 58.6% | 49.3% | 48.5% | 49.5% | 48.1% | 30.4% | 103.8% | 33.4% | 54.8% | 73.5% | 21.1% | 22.7% | 40.0% | |
| – | 376.1% | 160.4% | 96.1% | 61.3% | 55.8% | 67.1% | 67.2% | 67.6% | 76.1% | 69.6% | 71.2% | 76.2% | 81.3% | 72.8% | 53.6% | 52.4% | 59.3% | 48.4% | 44.1% | 32.3% | 38.7% | 34.1% | 66.1% | 45.5% | 46.6% | 43.7% | 45.4% | 36.4% | 33.2% | 30.7% | 38.2% | 27.4% | 24.9% | 17.9% | 22.6% | 23.0% | 29.0% | 14.9% | 26.8% | 22.1% | |
| – | 1,728.2% | 338.6% | 271.3% | 137.5% | 134.2% | 138.9% | 234.5% | 178.2% | 249.5% | 173.9% | 191.1% | 211.6% | 314.4% | 192.7% | 191.0% | 184.8% | 202.2% | 188.1% | 190.2% | 105.8% | 136.8% | 126.3% | 174.2% | 139.7% | 129.4% | 140.7% | 138.0% | 95.1% | 82.7% | 79.3% | 87.9% | 75.6% | 55.3% | 121.9% | 56.1% | 88.1% | 102.9% | 34.6% | 59.5% | 65.8% | |
| – | -1,630.6% | -240.1% | -180.9% | -99.9% | -40.4% | -47.6% | -140.7% | -89.3% | -165.1% | -87.8% | -290.9% | -124.8% | -230.0% | -103.8% | -100.7% | -95.2% | -117.6% | -103.4% | -102.1% | -18.2% | -52.5% | -41.2% | -90.4% | -57.0% | -41.3% | -54.5% | -51.1% | -6.3% | 6.2% | 8.4% | -0.2% | 4.8% | 24.6% | -40.3% | 18.9% | -25.9% | -92.9% | 49.0% | 3.3% | -7.3% | |
| – | 1.1% | 1.6% | 0.8% | 1.7% | 3.5% | 11.8% | 11.1% | 13.6% | 8.6% | 8.4% | 7.8% | 7.6% | 8.4% | 12.0% | 10.0% | 9.7% | 12.9% | 10.7% | 9.6% | 8.4% | 8.0% | 7.5% | 6.9% | 6.4% | 2.6% | 2.5% | 2.0% | 1.6% | 1.3% | 1.0% | 1.3% | 1.1% | 0.7% | 0.6% | 0.9% | 1.9% | 1.7% | 3.0% | 5.4% | 3.0% | |
| – | -1,631.7% | 526.8% | -180.4% | -99.5% | -45.1% | -54.5% | -147.8% | -98.2% | -167.8% | -88.0% | -291.8% | -127.3% | -234.7% | -15.3% | -109.8% | -136.5% | -129.9% | -113.9% | -49.8% | -25.3% | -60.5% | -49.4% | -97.7% | -111.4% | -39.2% | -202.3% | -5.6% | -10.0% | 10.2% | 10.0% | 3.7% | 7.3% | 26.1% | -51.5% | 25.1% | -48.6% | -62.8% | 47.0% | -0.4% | -6.6% | |
| – | -30.7% | 12.2% | -0.3% | 4.4% | -3.2% | 0.2% | 0.8% | -0.9% | -0.9% | 0.1% | 0.2% | 0.2% | 0.7% | 0.1% | 0.0% | 0.1% | 0.6% | -0.1% | -0.2% | 0.1% | 0.0% | 0.4% | 1.5% | 0.6% | 3.1% | 1.6% | 3.6% | 2.3% | -1.3% | 1.3% | 2.0% | 0.1% | 1.9% | 8.6% | -7.1% | -3.5% | 1.0% | 1.7% | 0.8% | 0.3% | |
| – | -1,631.7% | 514.6% | -180.1% | -103.9% | -41.9% | -54.7% | -148.6% | -97.3% | -166.9% | -88.1% | -292.0% | -127.5% | -235.4% | -15.4% | -109.8% | -136.5% | -130.4% | -113.8% | -49.6% | -25.4% | -60.5% | -49.8% | -99.1% | -111.9% | -42.3% | -203.8% | -9.2% | -12.3% | 11.5% | 8.7% | 1.8% | 7.2% | 24.2% | -60.1% | 32.2% | -45.1% | -63.9% | 45.3% | -1.2% | -6.9% | |
| – | -1,569.7% | -230.1% | -175.3% | -93.9% | -34.9% | -39.2% | -132.8% | -80.0% | -155.1% | -72.2% | -275.8% | -111.4% | -218.1% | 2.4% | -95.1% | -122.2% | -111.9% | -97.2% | -35.0% | -11.3% | -47.5% | -36.8% | -86.6% | -100.3% | -32.5% | -195.3% | 0.5% | -5.1% | 14.4% | 13.1% | 7.5% | 10.4% | 28.4% | -49.5% | 27.8% | -42.1% | -56.9% | 51.4% | 7.5% | -0.7% |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.